CClinicalTrials.gg
TerminatedNCT04857476PsACT-USUpdated Sep 19, 2024

Do Patients With Skin Psoriasis Have Sub-clinical Features of Active Psoriatic Arthritis on Musculoskeletal UltraSound?

An interventional study of Ultrasound scan in Psoriatic Arthritis, sponsored by The Royal Wolverhampton Hospitals NHS Trust. Terminated at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-09-19.

Sponsored by The Royal Wolverhampton Hospitals NHS Trust · Not applicable, Interventional, and Diagnostic

Why this study was terminated
Due to work commitment and time constraints, the study had to finish early..
Phase
Not applicable
Study type
Interventional
Enrollment
8
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Psoriatic Arthritis is an inflammatory condition that typically affects joints and soft tissues such as tendons. Poorly controlled or untreated psoriatic arthritis can lead to joint damage, disability and poor physical and mental wellbeing. Evidence suggests that early diagnosis and treatment of psoriatic arthritis can minimise adverse health outcomes.

Musculoskeletal ultrasound has become an extremely useful tool in aiding rheumatologists to diagnose inflammatory joint conditions particularly at an early stage in the course of a disease.

Psoriatic arthritis is known to affect up to 30% of patients with skin psoriasis. Therefore, national dermatology guidelines advise that patients with skin psoriasis should be asked about any joint symptoms at least every year.

This study investigates whether skin psoriasis patients who are not on biologic treatment are indeed being asked about any joint symptoms and we subsequently invite patients for a musculoskeletal ultrasound scan to see if they have features of early psoriatic arthritis on ultrasound. Those who do are then invited for a thorough rheumatology clinical assessment.

02

Conditions studied

  • Psoriatic Arthritis
03

In context

Arthritis

3,554 studies on the registry are indexed under Arthritis; 318 are open to participants now.

This study's enrollment of 8 is below the median of 90 across 2,377 interventional studies indexed under Arthritis.

Browse Arthritis studies →

Lead sponsor

The Royal Wolverhampton Hospitals NHS Trust is the lead sponsor of 49 studies on the registry; 14 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Diagnosis of Psoriasis by a dermatologist
  • Aged 18 or more
  • Reasonable fluency of spoken English

Exclusion criteria

Exclusion Criteria:

  • Existing diagnosis of Psoriatic arthritis
  • Currently on biologics for treatment of their skin Psoriasis (as this would potentially treat and thereby diminish joint symptoms associated with PsA)
  • Aged \<18years old (the study focusses on an adult population)
  • Currently in prison (would be unable to attend the study ultrasound scan)
  • Unable to give written consent for a musculoskeletal ultrasound e.g. advanced dementia, learning difficulties (may be unable to appreciate the reason for the study and may be unable to tolerate sitting relatively still for an ultrasound scan for 60 minutes)
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
8 participants (actual)

Study arms

  • Other
    skin psoriasis participants

    Single arm study

    Diagnostic Test: Ultrasound scan

Interventions

  • Diagnostic testUltrasound scan

    Psoriasis epidemiology screening tool (PEST) score for completion Brief questionnaire about current psoriasis symptoms, current treatment and if any features associated with psoriatic arthritis. One-off musculo-skeletal ultrasound Questionnaire at 2 years

06

What researchers measure

Primary outcomes

  1. Proportion of patients with known skin psoriasis have features in keeping with psoriatic arthritis on musculoskeletal ultrasound

    proportion of patients with known skin psoriasis have features in keeping with psoriatic arthritis on musculoskeletal ultrasound

    Time frame: 3 years

  2. Risk factors associated with those psoriasis patients who do have features of psoriatic arthritis on musculoskeletal ultrasound

    Are there any particular risk factors associated with those psoriasis patients who do have features of psoriatic arthritis on musculoskeletal ultrasound?

    Time frame: 3 years

  3. PEST Scores

    To identify whether patients who have higher PEST scores are more likely to have features of psoriatic arthritis on ultrasound

    Time frame: 3 years

  4. PEST score element

    Which element of a PEST score, if reported by a patient, is most likely to be associated with features of psoriatic arthritis on musculoskeletal ultrasound

    Time frame: 3 years

  5. High PEST score with normal ultrasound scan

    Are patients with a high PEST score and a normal initial musculoskeletal ultrasound scan more likely to be diagnosed with Psoriatic arthritis after 2 years

    Time frame: 2 years

07

Study locations

1 site
  • George Hirsch
    Wolverhampton, WV10 0QP, United Kingdom
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04857476
Lead sponsor
The Royal Wolverhampton Hospitals NHS Trust
Responsible party
Sponsor
First posted
Apr 23, 2021
Start date
Jun 22, 2021
Primary completion
Jul 30, 2021
Completion
Jul 30, 2021
Last update
Sep 19, 2024

Study contacts

George Hirsch
principal investigator · The Royal Wolverhampton NHS Trust

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion